Who owns Eiger Biopharmaceuticals?

Tip: Access positions for across all investors

Analyze quarterly positions in Eiger Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Eiger Biopharmaceuticals stock

Who bought or sold Eiger Biopharmaceuticals this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Ameriprise Financial 8.6M $2.6M 0% Sep 2023
 View chart
Propel Bio Management 4.4M $986k 100% Dec 2023
 View chart
683 Capital Management 2.1M $472k -21% Dec 2023
 View chart
Vanguard Group 1.8M $409k -7% Dec 2023
 View chart
BlackRock 886k $270k -5% Sep 2023
 View chart
UBS O'Connor 394k $120k 0% Sep 2023
 View chart
Rbf Capital 391k $119k 0% Sep 2023
 View chart
Geode Capital Management 380k $116k 0% Sep 2023
 View chart
Acadian Asset Management 238k $71k 15% Sep 2023
 View chart
State Street Corporation 147k $45k 0% Sep 2023
 View chart
Northern Trust 112k $34k -15% Sep 2023
 View chart
Bridgeway Capital Management 107k $33k -48% Sep 2023
 View chart
Millennium Management 81k $18k -70% Dec 2023
 View chart
Sequoia Financial Advisors 63k $14k 0% Dec 2023
 View chart
Verition Fund Management 63k $19k -58% Sep 2023
 View chart
Two Sigma Securities 57k $13k 60% Dec 2023
 View chart
Bank of America Corporation 48k $11k -4% Dec 2023
 View chart
Tocqueville Asset Management 37k $8.4k -27% Dec 2023
 View chart
Charles Schwab Investment Management 33k $7.5k 0% Dec 2023
 View chart
Dfpg Investments 32k $8.0k 0% Dec 2023
 View chart
Townsquare Capital 32k $7.3k 0% Dec 2023
 View chart
Jane Street 30k $6.6k 100% Dec 2023
 View chart
Morgan Stanley 30k $9.0k -51% Sep 2023
 View chart
Hrt Financial 29k $6.0k 100% Dec 2023
 View chart
Susquehanna International 22k $6.6k -48% Sep 2023
 View chart
Bank of New York Mellon 21k $4.6k 0% Dec 2023
 View chart
Tower Research Capital 17k $5.0k 4% Sep 2023
 View chart
XTX Topco 16k $4.8k -72% Sep 2023
 View chart
Engineers Gate Manager 15k $4.4k 8% Sep 2023
 View chart
Citadel Advisors 14k $3.2k 100% Dec 2023
 View chart
Simplex Trading 13k $2.0k 7% Dec 2023
 View chart
UBS Group 11k $2.2k 19277% Dec 2023
 View chart
Advisor Group Holdings 7.8k $1.7k -65% Dec 2023
 View chart
Qube Research & Technologies 6.1k $1.9k -90% Sep 2023
 View chart
Citigroup 2.9k $535.219200 -21% Dec 2023
 View chart
Bnp Paribas Arbitrage, Snc 2.9k $651.948000 -1% Dec 2023
 View chart
Rhumbline Advisers 2.3k $522.000000 0% Dec 2023
 View chart
Royal Bank of Canada 1.4k $0 45% Dec 2023
 View chart
National Bank Of Canada /fi/ 1.3k $301.056000 0% Dec 2023
 View chart
Cutler 1.0k $0 0% Dec 2023
 View chart
Sound Income Strategies 400.00 $90.000000 0% Dec 2023
 View chart
Wells Fargo & Company 307.00 $69.351300 -98% Dec 2023
 View chart
Perkins Coie Trust 178.00 $38.999800 0% Dec 2023
 View chart
Jpmorgan Chase & Co 166.00 $37.001400 -98% Dec 2023
 View chart

Who sold out of Eiger Biopharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Simplify Asset Management Sep 2023 2.7M $824k
GSA Capital Partners Sep 2023 356k $109k
Y-Intercept Jun 2023 161k $114k
DRW Holdings Sep 2023 120k $37k
Renaissance Technologies Jun 2023 72k $50k
Sigma Planning Sep 2023 42k $13k
Ergoteles Jun 2023 41k $29k
Old Mission Capital Jun 2023 27k $19k
Two Sigma Investments Sep 2023 18k $5.5k
FMR Jun 2023 1.6k $1.1k
China Universal Asset Management Sep 2023 1.1k $0
Toth Financial Advisory Corporation Sep 2023 335.00 $103.012500